Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Incorporation into DNA encompasses both normal addition of deoxynucleotides by high-fidelity enzymes as well as occasional misincorporation of ribonucleotides due to their abundance. This phenomenon has important implications for genomic integrity and serves as a focal point in studies on mutation rates, disease mechanisms related to faulty repair systems, biomarker development for enzymology research, and biotechnological applications such as sequencing technologies.
N/A (not a drug target directly, but a process affected by drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Incorporation into DNA (None).